Gene · 716
Papers3,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,161 to 1,180 of 3,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Case Report: Compromised Airway Following Anesthesia and Its Correlation With the Use of ACE Inhibitors-An Unexpected Clinical Event and Review of Literature. | Front Surg | 2021 | 33829036 | PubTator, text mining | PubMed |
| SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation. | Sci Immunol | 2021 | 33827897 | PubTator, text mining | PubMed |
| Insight into the human pathodegradome of the V8 protease from Staphylococcus aureus. | Cell Rep | 2021 | 33826899 | PubTator, text mining | PubMed |
| Sutimlimab in Cold Agglutinin Disease. | N Engl J Med | 2021 | 33826820 | PubTator, text mining | PubMed |
| Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. | Nat Rev Immunol | 2021 | 33824483 | PubTator, text mining | PubMed |
| Reducing neutrophil exposure to oxygen allows their basal state maintenance. | Immunol Cell Biol | 2021 | 33811670 | PubTator, text mining | PubMed |
| An update: the emerging evidence of complement involvement in COVID-19. | Med Microbiol Immunol | 2021 | 33811541 | PubTator, text mining | PubMed |
| Aqueous Humor Proteomic Alterations Associated with Visual Field Index Parameters in Glaucoma Patients: A Pilot Study. | J Clin Med | 2021 | 33808966 | PubTator, text mining | PubMed |
| Large Scale Molecular Studies of Pituitary Neuroendocrine Tumors: Novel Markers, Mechanisms and Translational Perspectives. | Cancers (Basel) | 2021 | 33808624 | PubTator, text mining | PubMed |
| Heat-Inactivation of Human Serum Destroys C1 Inhibitor, Pro-motes Immune Complex Formation, and Improves Human T Cell Function. | Int J Mol Sci | 2021 | 33808005 | PubTator, text mining | PubMed |
| Rare Variants in Autophagy and Non-Autophagy Genes in Late-Onset Pompe Disease: Suggestions of Their Disease-Modifying Role in Two Italian Families. | Int J Mol Sci | 2021 | 33807278 | PubTator, text mining | PubMed |
| The Impact of Complement Genes on the Risk of Late-Onset Alzheimer's Disease. | Genes (Basel) | 2021 | 33804666 | PubTator, text mining | PubMed |
| Difficult Cases of Paroxysmal Nocturnal Hemoglobinuria: Diagnosis and Therapeutic Novelties. | J Clin Med | 2021 | 33804461 | PubTator, text mining | PubMed |
| Severe COVID-19 Infection Associated with Endothelial Dysfunction Induces Multiple Organ Dysfunction: A Review of Therapeutic Interventions. | Biomedicines | 2021 | 33801921 | PubTator, text mining | PubMed |
| Emerging Therapies in Immune Thrombocytopenia. | J Clin Med | 2021 | 33801294 | PubTator, text mining | PubMed |
| Network Analysis and Transcriptome Profiling Identify Autophagic and Mitochondrial Dysfunctions in SARS-CoV-2 Infection. | Front Genet | 2021 | 33796130 | PubTator, text mining | PubMed |
| Cellular and molecular mechanisms breaking immune tolerance in inborn errors of immunity. | Cell Mol Immunol | 2021 | 33795850 | PubTator, text mining | PubMed |
| Classical complement and inflammasome activation converge in CD14highCD16- monocytes in HIV associated TB-immune reconstitution inflammatory syndrome. | PLoS Pathog | 2021 | 33788899 | PubTator, text mining | PubMed |
| Transmembrane protein DCBLD2 is correlated with poor prognosis and affects phenotype by regulating epithelial-mesenchymal transition in human glioblastoma cells. | Neuroreport | 2021 | 33788813 | PubTator, text mining | PubMed |
| Novel Compounds Targeting Neuropilin Receptor 1 with Potential To Interfere with SARS-CoV-2 Virus Entry. | ACS Chem Neurosci | 2021 | 33787218 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/716/papers?page=59